Pandemic Pulse

A study published in The Lancet confirms the one-shot Sputnik Light vaccine has a high safety profile and induces a strong humoral and cellular immune response both in the seronegative and seropositive groups

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces a new publication by the Gamaleya Center in The Lancet, one of the world’s most respected medical journals, showing the one-shot Sputnik Light vaccine against coronavirus demonstrates a high safety profile and induces a strong humoral and cellular immune response. RDIF has sponsored the […]